Great Lakes Dredge & Dock Corporation (GLDD) Drops 5.43% on January 07

Equities Staff |

Great Lakes Dredge & Dock Corporation (GLDD) was one of the Russell 2000's biggest losers for Thursday January 07 as the stock slid 5.43% to $3.48, a loss of $-0.2 per share. Starting at an opening price of $3.63 a share, the stock traded between $3.47 and $3.65 over the course of the trading day. Volume was 136,993 shares over 637 trades, against an average daily volume of 277,957 shares and a total float of 60.45 million.

The losses send Great Lakes Dredge & Dock Corporation down to a market cap of $210.35 million. In the last year, Great Lakes Dredge & Dock Corporation has traded between $8.31 and $3.66, and its 50-day SMA is currently $4.15 and 200-day SMA is $5.26.

The stock has a P/E Ratio of 16.3.

Great Lakes Dredge & Dock Corp is a provider of dredging services in the United States. The Company also owns specialty contracting service providers which primarily offers environmental, remediation and geotechnical services throughout the USA.

Great Lakes Dredge & Dock Corporation is based out of Oak Brook, IL and has some 1,598 employees. Its CEO is Jonathan W. Berger.

For a complete fundamental analysis analysis of Great Lakes Dredge & Dock Corporation, check out Equities.com’s Stock Valuation Analysis report for GLDD. To see the latest independent stock recommendations from Equities.com’s analysts, visit our Research section.

The Russell 2000 is one of the leading indices tracking small-cap companies in the United States. It's maintained by Russell Investments, an industry leader in creating and maintaining indices, and consists of the smallest 2000 stocks from the broader Russell 3000 index.

Russell's indices differ from traditional indices like the Dow Jones Industrial Average (DJIA) or S&P 500, whose members are selected by committee, because they base membership entirely on an objective, rules based methodology. The 3,000 largest companies by market cap make up the Russell 3000, with the 2,000 smaller companies making up the Russell 2000. It's a simple approach that gives a broad, unbiased look at the small-cap market as a whole.

For more news on the financial markets, go to Equities.com. Also, learn more about our independent proprietary equity research reports and our robust do-it-yourself Stock Valuation Analysis reports in our Research section.

All data provided by QuoteMedia and was accurate as of 4:30PM ET.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer

Comments

Emerging Growth

Immunovaccine Inc.

Immunovaccine Inc is clinical stage biopharmaceutical company. The Company develops products based on its proprietary vaccine enhancement platform in T cell activating therapies for cancer.

Private Markets

BioSculpture Technology, Inc.

BioSculpture Technology, Inc. (“BST”) is a commercial-stage medical device manufacturer of liposuction surgical instruments for surgeons. It offers the FDA-cleared Twin Cannula Assisted Liposuction ("TCAL") Airbrush Liposculptor II® controllers, Airbrush®…

Wealthfront

Wealthfront is an automated investment service that serves as an alternative to traditional financial advisory services. The company manages a diversified, continually rebalanced portfolio of index funds on their clients’…